Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.194 USD | +1.68% | -2.22% | +33.43% |
Apr. 03 | North American Morning Briefing : Powell Awaited -2- | DJ |
Mar. 28 | Galera Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 7.91M |
---|---|---|---|---|---|
Net income 2022 | -62M | Net income 2023 | -59M | EV / Sales 2022 | - |
Net Debt 2022 | 108M | Net Debt 2023 | 134M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.65
x | P/E ratio 2023 |
-0.11
x | Employees | 7 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.8% |
1 day | +1.68% | ||
1 week | -2.22% | ||
Current month | +38.57% | ||
1 month | -13.39% | ||
3 months | +7.48% | ||
6 months | +7.78% | ||
Current year | +33.43% |
Managers | Title | Age | Since |
---|---|---|---|
Dennis P. Riley
FOU | Founder | - | 08-12-31 |
J. Sorensen
CEO | Chief Executive Officer | 67 | 12-10-31 |
Robert Beardsley
FOU | Founder | 63 | 08-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Beardsley
FOU | Founder | 63 | 08-12-31 |
Michael Powell
CHM | Chairman | 69 | 16-11-27 |
Kevin Lokay
BRD | Director/Board Member | 67 | 19-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 0.1908 | +3.70% | 676,605 |
24-04-19 | 0.184 | -1.08% | 804,210 |
24-04-18 | 0.186 | -6.25% | 4,160,571 |
24-04-17 | 0.1984 | +16.71% | 18,270,307 |
24-04-16 | 0.17 | +11.18% | 3,817,896 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+33.43% | 10.38M | |
-0.49% | 103B | |
+3.31% | 96.73B | |
+1.66% | 21.31B | |
-16.16% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
-22.87% | 13.68B | |
+6.32% | 13.44B | |
+21.46% | 10.98B |
- Stock Market
- Equities
- GRTX Stock